Publication: MET Exon 14 Skipping and Novel Actionable Variants: Diagnostic and Therapeutic Implications in Latin American Non-Small-Cell Lung Cancer Patients
Authors
Rivas, Solange
Sepúlveda, Romina V.
Tapia, Ignacio
Estay, Catalina
Soto, Vicente
Blanco, Alejandro
González, Evelin
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
20 p.
item.page.accessRights
Acceso abierto
item.page.other
item.page.references
Abstract
Targeted therapy indications for actionable variants in non-small-cell lung cancer (NSCLC) have primarily been studied in Caucasian populations, with limited data on Latin American patients. This stud...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Rivas, S.; Sepúlveda, R.V.; Tapia, I.; Estay, C.; Soto, V.; Blanco, A.; González, E.; Armisen, R. MET Exon 14 Skipping and Novel Actionable Variants: Diagnostic and Therapeutic Implications in Latin American Non-Small-Cell Lung Cancer Patients. Int. J. Mol. Sci. 2024, 25, 13715. https://doi.org/10.3390/ ijms252413715
item.page.dc.rights
Atribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL)
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Agosto 2025Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026